Results from the first randomized clinical trial testing hydroxychloroquine for the post-exposure prevention of COVID-19 that were published in the New England Journal of Medicine determined that hydroxychloroquine was not able to prevent the development of COVID-19 any better than a placebo.
Other News
On what do the experts agree? The omicron variant is one of the most transmissible viruses known.
I’m vaccinated, now what? First, thank you! Second, if you haven’t yet, schedule your booster shot.
With students, many staff, faculty, and researchers already on campus, and others making plans to return this fall, I want to acknowledge…